Literature DB >> 29779230

Role of mu, but not delta or kappa, opioid receptors in context-induced reinstatement of oxycodone seeking.

Jennifer M Bossert1, Jennifer K Hoots1, Ida Fredriksson1, Sweta Adhikary1, Michelle Zhang1, Marco Venniro1, Yavin Shaham1.   

Abstract

Relapse to non-medical use of prescription opioids often occurs after exposure to places previously associated with drug use. Here, we describe a rat model of context-induced reinstatement of oxycodone seeking after repeated cycles of drug self-administration and extinction-induced abstinence. We also determined the role of mu, delta and kappa opioid receptors (MOR, DOR, KOR) in this reinstatement. We trained rats to self-administer oxycodone for 6 h/day in context A; lever pressing was paired with a discrete cue. Next, we extinguished the lever pressing in the presence of the discrete cue in context B and then tested the rats for reinstatement of oxycodone seeking in both contexts. We retrained rats to self-administer oxycodone in context A, re-extinguished their lever pressing in context B and retested them for reinstatement in both contexts. Prior to testing, we injected the rats with vehicle or antagonists of MOR (naltrexone; 0.5 or 1.0 mg/kg), DOR (naltrindole; 7.5 or 15 mg/kg) or KOR (LY2456302; 5 or 10 mg/kg). We also tested the effect of naltrexone, naltrindole and LY2456302 on oxycodone self-administration under fixed-ratio-1 (FR1) and progressive ratio (PR) reinforcement schedules. We observed context-induced reinstatement of oxycodone seeking after repeated cycles of drug self-administration and extinction. Naltrexone, but not naltrindole or LY2456302, injections decreased this reinstatement. Additionally, naltrexone increased oxycodone self-administration under the FR1 schedule and decreased oxycodone self-administration under the PR schedule; naltrindole and LY2456302 were ineffective. Results demonstrate a critical role of MOR, but not DOR or KOR, in context-induced reinstatement of oxycodone seeking and oxycodone self-administration. Published 2018. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  context; drug self-administration; extinction; opioid receptors; oxycodone; reinstatement

Mesh:

Substances:

Year:  2018        PMID: 29779230     DOI: 10.1111/ejn.13955

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  16 in total

1.  Escalated Oxycodone Self-Administration Causes Differential Striatal mRNA Expression of FGFs and IEGs Following Abstinence-Associated Incubation of Oxycodone Craving.

Authors:  Christopher A Blackwood; Michael Leary; Aaron Salisbury; Michael T McCoy; Jean Lud Cadet
Journal:  Neuroscience       Date:  2019-07-24       Impact factor: 3.590

2.  Lasting effects of repeated ∆9 -tetrahydrocannabinol vapour inhalation during adolescence in male and female rats.

Authors:  Jacques D Nguyen; Kevin M Creehan; Tony M Kerr; Michael A Taffe
Journal:  Br J Pharmacol       Date:  2019-10-31       Impact factor: 8.739

3.  Addiction in focus: molecular mechanisms, model systems, circuit maps, risk prediction and the quest for effective interventions.

Authors:  Rita Z Goldstein; Michel Barrot; Barry J Everitt; John J Foxe
Journal:  Eur J Neurosci       Date:  2019-08       Impact factor: 3.386

Review 4.  Relapse to opioid seeking in rat models: behavior, pharmacology and circuits.

Authors:  David J Reiner; Ida Fredriksson; Olivia M Lofaro; Jennifer M Bossert; Yavin Shaham
Journal:  Neuropsychopharmacology       Date:  2018-10-06       Impact factor: 7.853

5.  Effect of the dopamine stabilizer (-)-OSU6162 on potentiated incubation of opioid craving after electric barrier-induced voluntary abstinence.

Authors:  Ida Fredriksson; Sarah V Applebey; Angelica Minier-Toribio; Aniruddha Shekara; Jennifer M Bossert; Yavin Shaham
Journal:  Neuropsychopharmacology       Date:  2020-01-06       Impact factor: 7.853

Review 6.  Considering Drug-Associated Contexts in Substance Use Disorders and Treatment Development.

Authors:  Mandy Rita LeCocq; Patrick A Randall; Joyce Besheer; Nadia Chaudhri
Journal:  Neurotherapeutics       Date:  2020-01       Impact factor: 7.620

7.  Pre-training naltrexone increases conditioned fear learning independent of adolescent alcohol consumption history.

Authors:  Alisa Pajser; Hayley Fisher; Charles L Pickens
Journal:  Physiol Behav       Date:  2020-10-16

8.  Novel Dual-Target μ-Opioid Receptor and Dopamine D3 Receptor Ligands as Potential Nonaddictive Pharmacotherapeutics for Pain Management.

Authors:  Alessandro Bonifazi; Francisco O Battiti; Julie Sanchez; Saheem A Zaidi; Eric Bow; Mariia Makarova; Jianjing Cao; Anver Basha Shaik; Agnieszka Sulima; Kenner C Rice; Vsevolod Katritch; Meritxell Canals; J Robert Lane; Amy Hauck Newman
Journal:  J Med Chem       Date:  2021-05-20       Impact factor: 8.039

9.  In a Rat Model of Opioid Maintenance, the G Protein-Biased Mu Opioid Receptor Agonist TRV130 Decreases Relapse to Oxycodone Seeking and Taking and Prevents Oxycodone-Induced Brain Hypoxia.

Authors:  Jennifer M Bossert; Eugene A Kiyatkin; Hannah Korah; Jennifer K Hoots; Anum Afzal; David Perekopskiy; Shruthi Thomas; Ida Fredriksson; Bruce E Blough; S Stevens Negus; David H Epstein; Yavin Shaham
Journal:  Biol Psychiatry       Date:  2020-02-24       Impact factor: 13.382

10.  Sex differences in oral oxycodone self-administration and stress-primed reinstatement in rats.

Authors:  Hannah D Fulenwider; Sadie E Nennig; Hiba Hafeez; Michaela E Price; Federico Baruffaldi; Marco Pravetoni; Kejun Cheng; Kenner C Rice; Daniel F Manvich; Jesse R Schank
Journal:  Addict Biol       Date:  2019-12-12       Impact factor: 4.093

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.